Skip to Content
Still using that old version of Internet Explorer? This site will work much better in a newer version of IE or Firefox.
Download Internet Explorer 8 or Firefox 3 now!

clinical trials

Ally Olotu

Ally Olotu-Clinical.jpg
Email: 
aolotuatkilifi [dot] kemri-wellcome [dot] org
Group: 
Clinical Group

Ally Olotu is a research clinician working with Clinical Trial Facility.He has been the co-principal investigator in the RTS,S phase IIb trial as well as sub-investigator in ph

Current and planned clinical trials

SHORT TITLEFULL TITLE

Approval process for conducting a trial

All research involving human participants is subject to regulation and approval by KEMRI, Ministry of Health and/or secondary Institutional Review Boards.

Quality policies and SOPs

We have developed in house standards and policies which are available on our intranet or upon request by interested parties.

About CTF

Brief History of CTF

Why clinical trials?

It is important to continue doing research because "even the best proven prophylactic, diagnostic and therapeutic methods must continuously be challenged through research for their effectiveness, e

A word from the head of the Clinical Trials Facility

We are delighted to welcome you to our site.

Patricia Njuguna

Email: 
pnjugunaatkilifi [dot] kemri-wellcome [dot] org
Group: 
Clinical Group

Patricia Wambui Njuguna is Paediatrician based in Kilifi, Kenya. She graduated with a Masters in Medicine (Paediatrics and Child Health) (University of Nairobi) in 2006.

Philip Bejon

Email: 
pbejonatkilifi [dot] kemri-wellcome [dot] org
Group: 
Clinical Group

I work with Ally Olotu, Roma Chilengi and Patricia Njuguna on a series of field trials on the candidate malaria vaccine RTS,S/AS01E.

Phase III Trial of RTS,S (RTSS)

Full Title: 
A phase III, double blind (observer-blind), randomized, controlled multi-center study to evaluate, in infants and children, the efficacy of the RTS,S/AS01E candidate vaccine against malaria disease caused by P. falciparum infection, across diverse malaria transmission settings in Africa.
Other Investigator(s): 
Patricia Njuguna